Annual report, 2007

The Patented Medicine Prices Review Board (PMPRB) is an independent quasi-judicial body established by Parliament in 1987 under the Patent Act (Act). It operates independently of other bodies such as Health Canada, which approves drugs for safety and efficacy, and public drug plans, which approve the listing of drugs on their respective formularies for reimbursement purposes. This document is the annual report of the PMPRB for the year ended December 31, 2007. The report provides detailed information on sales and price trends of medicines in Canada, including internaitonal comparisons; patentees' compliance with the Board's Excessive Price Guidelines; enforcement activities and hearings; and patentees' R & D spending.--Includes text from the publisher's website.